TDO2 and cancer: Similar to IDO, tryptophan 2,3-dioxygenase (TDO) is expressed by cancer cells in various human tumors (Pilotte et al., 2012) and its activity, presumably through tryptophan depletion or kynurenine (Box 1) production, induces immune dysfunction (Schmidt et al., 2009).